ReviewAntibody therapeutics2022
Chimeric antigen receptor T-cell therapy: challenges and opportunities in lung cancer.
Caili Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papercites it
ReviewAntibody therapeutics2022
Caili Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.